RecruitingNCT07258459

Two Previous Cesarean and Vaginal Birth Before and After Starting Training and Protocols

Trial of Labor After Two CS Before and After Training a Protocol Introduction


Sponsor

G. d'Annunzio University

Enrollment

2,016 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

In 2015 ObGyn Dept of Santo Spirito Hospital in Pescara (Italy) started protocol for previous CS vaginal birth. In 2021 was started a protocol for training on obstetric emergencies and protocol on two previous cesarean was endorsed. Patients attending birth in Pescara with two previous from january 2016 to December 2020, and from january 2021 to december 2025 were collected. A different counseling approach was adopted from 2021. Women's acceptance of trial of labor and maternal and fetal outcomes were collected.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Acceptance, rate of vaginal birth and safety for people with cesarean delivery affecting fetus or newborn, hemorrhagic complications, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAcceptance, rate of vaginal birth and safety

In 2021 started a new delivery protocol enhancing the opportunity of having a trial of labor in women with a history of two previous CS. Rate of acceptance, rate of successful vaginal birth, maternal and fetal outcomes were evaluated


Locations(2)

Claudio Celentano

Pescara, PE, Italy

Santo Spirito Hospital

Pescara, PE, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07258459


Related Trials